However, several factors can compromise carnitine status: caloric restriction (which reduces dietary intake), certain medications, chronic kidney disease, and strict vegetarian or vegan diets
The L Carnitine industry is projected to grow from USD 1.735 Billion in 2025 to USD 3.785 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 8.11% during the forecast period 2025 - 2035 Key Market Trends & Highlights The L-Carnitine market is experiencing robust growth driven by health trends and evolving consumer preferences
Our philosophy with love for those in love defines everything we do
doi: 10.1093/nar/gkae973 Summary Keywords atheroscelrosis, cholesterol metabolism, acetyl-L-carnitine (ALC), SREBP2, HMGCR Citation Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, Han L, Sun X, Sun H, Du Y, Hu C, Yu H and Qin Y (2024) Acetyl-L-carnitine ameliorates atherosclerosis in LDLR / mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis